SCHEMBL6889157

SCHEMBL6889157

COCCn1c(-c2ccccc2F)nc2ccc(N3CCN4CCC3CC4)cc2c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
HTT P42858 1/20 0.42
CHRNA7 P36544 2/20 0.42
CHRNA1 P02708 1/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
CHRNA4 P43681 1/20 0.42
HTR3A P46098 1/20 0.42
GHSR Q92847 2/20 0.42
GNRHR P30968 1/20 0.40
CASR P41180 3/20 0.39
KCNH2 Q12809 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
POLB P06746 1/20 0.39
TSHR P16473 2/20 0.39
CYP2D6 P10635 1/20 0.39
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6886382 0.89 CHRNA7 (0.44) CHRNA7CHRNA1CHRNB2CHRNB4CHRNA3
SCHEMBL6891194 0.87 CHRNA7 (0.43) CHRNA7CHRNA1CHRNB2CHRNB4CHRNA3
SCHEMBL6887916 0.85 CHRNA7 (0.43) ALDH1A1CHRNA7KCNH2POLBTSHR
SCHEMBL6887465 0.85 CHRNA7 (0.48) CHRNA7CHRNA1CHRNB2CHRNB4CHRNA3
SCHEMBL6886315 0.85 HPGD (0.42) ALDH1A1CHRNA7POLBKDM4E
SCHEMBL6889887 0.84 CHRNA7 (0.40) ALDH1A1HTTCHRNA7POLBTSHR
SCHEMBL6886562 0.83 ALDH1A1 (0.45) ALDH1A1ALOX15HSD17B10POLBTSHR
SCHEMBL6888036 0.83 CHRNA7 (0.43) CHRNA7CHRNA1CHRNB2CHRNB4CHRNA3
SCHEMBL6886312 0.83 HPGD (0.40) ALDH1A1CHRNA7POLBKDM4E
SCHEMBL6887545 0.82 BRD4 (0.46) ALDH1A1HTTCHRNA7HSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488520-B1 CONDENSED AZINE-DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME (NL) 2015-09-02 EP disclosed
EP-2488520-B1 CONDENSED AZINE-DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME (NL) 2015-09-02 EP disclosed
US-8841289-B2 Heterocyclic derivatives MERCK SHARP & DOHME B.V. (US) 2014-09-23 US disclosed
US-8841289-B2 Heterocyclic derivatives MERCK SHARP & DOHME B.V. (US) 2014-09-23 US disclosed
US-8841289-B2 Heterocyclic derivatives MERCK SHARP & DOHME B.V. (US) 2014-09-23 US disclosed
US-20120208796-A1 HETEROCYCLIC DERIVATIVES ORGANON BIOSCIENCES NEDERLAND B.V. (NL) 2012-08-16 US disclosed
US-20120208796-A1 HETEROCYCLIC DERIVATIVES ORGANON BIOSCIENCES NEDERLAND B.V. (NL) 2012-08-16 US disclosed
US-20120208796-A1 HETEROCYCLIC DERIVATIVES ORGANON BIOSCIENCES NEDERLAND B.V. (NL) 2012-08-16 US disclosed
WO-2011045258-A1 CONDENSED AZINE - DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE ACETYLCHOLINE RECEPTOR N.V. ORGANON (NL) 2011-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208796-A1 HETEROCYCLIC DERIVATIVES CHRNA5, CHRM5, CHRNA7 ALDH1A1 732/4885HTT 170/4885CHRNA7 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.